Q&A: Changing the (invented) name of a centrally authorised medicinal product

Once a veterinary product has received approval from the Commission (the “Commission Decision”) all further procedures connected with the product will fall under “post-authorisation procedures”.

The guidance published under ‘Post-authorisation procedural Q&A ’’ provides an overview for different types of post-authorisation procedures that occur frequently and, in each case, addresses a number of questions which marketing authorisation holders (MAHs) may have.

Additional information


How useful was this page?

Add your rating